Navigation Links
Flavonoids In Orange Juice Make It A Healthy Drink, Despite The Sugar

from the fructose, orange juice or water group.

"We were intrigued by the fact that there was no increase in ROS or inflammation following orange juice consumption, even though its glucose concentration was the same as in participants in the glucose group," said Dandona. "This raised the question of what in the juice was responsible for suppressing ROS generation: flavonoids and vitamin C or fructose?"

An additional round of test on the samples showed that neither fructose nor vitamin C suppressed the oxygen free radicals. However the two types of flavonoids in orange juice -- hesperetin and naringenin -- inhibited ROS generation by 52 percent and 77 percent, respectively.

"Our data are relevant to patients with diabetes," said Dandona, "because stress from ROS and inflammation are increased significantly in this population and may contribute to development of atherosclerosis. Clearly the choice of foods that either don't increase or actually decrease oxidative and inflammatory stress is important.

"The search for safe non-inflammatory foods and diets must continue," Dandona stressed, "especially since obesity, being overweight and type 2 diabetes are associated with oxidative stress and inflammation, and more than 60 percent of U.S. population is affected by these conditions."


'"/>




Page: 1 2

Related medicine news :

1. Foods Rich In Flavonoids Effective In Prevention Of Cough
2. Science Stacks Up for Flavonoids for Heart Health
3. A Glass of Orange Juice To Keep Recurrence Of Kidney Stones At Bay
4. Eating Live Crabs Infects 8 In Orange County
5. Mandarin Oranges Reduce Liver Cancer Risk
6. Pass the Orange Tomato Sauce Please
7. An Orange a Day may Keep Heart Disease Away
8. Veterans Exposed to Agent Orange Increased Risk of Prostate Cancer Recurrence
9. Juices are Best! but which one?
10. Pomegranate Juice May Be The Next Best Thing For People With Heart Disease
11. Pomegranate Juice Is Helpful In Arresting Osteoarthritis
Post Your Comments:
(Date:5/16/2008)...kard, from Griffiths School of Nursing and Midwife...the HESTA Australian Nursing Awards. , Professo...patient blood loss during testing procedures, redu...ansfusions among already ill patients. The award w...rnes Crown Entertainment complex. , Nurses rout...
(Date:5/16/2008)...on Public Service Announcement Available, RADNOR,...ition of,National Mental Health Month and Older Pe...n Council (SPC) will offer an important message to...ment. The public service,announcement developed by...o the public health problem of depression and to o...
(Date:5/16/2008)... appointment of Nomura Code Securities Limited as ...r, NEW YORK, May 16 /PRNewswire-FirstCall/ -- Med...ts, Inc. (Amex: MGT ) (the "Company"), and an,ind...Detection (CAD) and,image analysis software which ...sease, today announced the appointment of NM Roths...
(Date:5/16/2008)...16 /PRNewswire/ -- Barbara Senich, B.S.N., M.B.A.,... Services, was honored by,Executive Women of New J...2008 Awards Dinner. The biennial event, held May 1...ized women of professional distinction in New,Jers...of directors at major,New Jersey-based corporation...
Breaking Medicine News(10 mins):Health News:Research talent wins national Innovation in Nursing award 2Health News:Suicide Prevention Group Delivers Much-Needed Message to Pennsylvania's Elderly 2Health News:Medicsight Announces Appointment of NM Rothschild & Sons Limited as Corporate Adviser 2Health News:Medicsight Announces Appointment of NM Rothschild & Sons Limited as Corporate Adviser 3Health News:Roche Vice President Senich Honored at EWNJ 'Salute to Policy Makers' 2Health News:Roche Vice President Senich Honored at EWNJ 'Salute to Policy Makers' 3
...ntified how depression plays an important role in ...normal heart beats in a depressed person that can ...or for increased risk of death from heart disease....ington University School of Medicine in St. Louis ...
...led sterols might help to lower your "bad" LDL cho... have been shown to block cholesterol's absorption... minimally absorbed by the intestines. The study ...the cases had high cholesterol, and 14 also had ty...
... of ancient Indian exercise and meditation for the... properties and is popularly used to relieve peopl... trauma and anxiety in patients with breast cance...Bangalore Institute of Oncology on Yoga therapy tr...
...nt found in turmeric or curry powder can prevent t... A new study had found that curcumin, a chemical ...that is required for certain forms of cancer to sp...its a protein called nuclear factor-kappa B (NF-kB...
Other Medicine News:Health News:Yoga Can Be Good For Breast Cancer Patients 2
(Date:5/15/2008)...5 /- Ergonex Pharma today,announced t... (FDA) has,granted orphan drug designation to Terg...rtension (PAH). Terguride is currently being evalu...., "The FDA,s grant of orphan drug designation to...development program by offering regulatory,clinic...
(Date:5/15/2008).../- Tigris Pharmaceuticals,Inc. annou... and,Development Agreement (CRADA) with the Nation...al and preclinical development of AFP-464, an,amin... is converted to,metabolites which bind covalently...., This is part of a four-year CRADA encompassing...
(Date:5/15/2008)...for an Antiplatelet Therapy that, Combined, with A...of Plavix/Iscover and Aspirin, According to a ...., May 15 /- Decision Resources, one ... for pharmaceutical and,healthcare issues, finds t...ovement in patient compared to Sanofi-Aventis/Bris...
(Date:5/15/2008)...er CEA Trial data reports in third quarter ...15 /- VIA Pharmaceuticals,...used on the development of,compounds for the treat...at,it has completed patient enrollment in its acut...one of three Phase 2 trials investigating VIA-2291...
Breaking Medicine Technology:Terguride Receives FDA Orphan Drug Designation for the Treatment of Pulmonary Arterial Hypertension 2Tigris Pharmaceuticals Signs CRADA with the National Cancer Institute 2Tigris Pharmaceuticals Signs CRADA with the National Cancer Institute 3Daiichi Sankyo/Eli Lilly's Effient and Astrazeneca's Ticagrelor May Offer Advantages in the Treatment of Post-Myocardial Infarction 2Daiichi Sankyo/Eli Lilly's Effient and Astrazeneca's Ticagrelor May Offer Advantages in the Treatment of Post-Myocardial Infarction 3VIA Pharmaceuticals Completes Enrollment in Phase 2 Acute Coronary Syndrome (ACS) Trial 2VIA Pharmaceuticals Completes Enrollment in Phase 2 Acute Coronary Syndrome (ACS) Trial 3VIA Pharmaceuticals Completes Enrollment in Phase 2 Acute Coronary Syndrome (ACS) Trial 4VIA Pharmaceuticals Completes Enrollment in Phase 2 Acute Coronary Syndrome (ACS) Trial 5Rosetta Genomics and Columbia University Medical Center to Develop MicroRNA based Diagnostics for Leukemia and Non Hodgkin Lymphoma 2185 1Rosetta Genomics and Columbia University Medical Center to Develop MicroRNA based Diagnostics for Leukemia and Non Hodgkin Lymphoma 2185 2Rosetta Genomics and Columbia University Medical Center to Develop MicroRNA based Diagnostics for Leukemia and Non Hodgkin Lymphoma 2185 3Rosetta Genomics and Columbia University Medical Center to Develop MicroRNA based Diagnostics for Leukemia and Non Hodgkin Lymphoma 2185 4Rosetta Genomics and Columbia University Medical Center to Develop MicroRNA based Diagnostics for Leukemia and Non Hodgkin Lymphoma 2185 5Genmab Announces Details of Planned Ofatumumab Phase II Study in Multiple Sclerosis 2180 1Genmab Announces Details of Planned Ofatumumab Phase II Study in Multiple Sclerosis 2180 2Genmab Announces Details of Planned Ofatumumab Phase II Study in Multiple Sclerosis 2180 3Anesiva Raises 2445 Million in Common Stock Offering 2178 1Anesiva Raises 2445 Million in Common Stock Offering 2178 2Cell Therapeutics Inc Announces Issuance of 2423 25 Million in New Convertible Senior Notes in Exchange for 2436 08 Million of Existing Convertibl 2175 1Cell Therapeutics Inc Announces Issuance of 2423 25 Million in New Convertible Senior Notes in Exchange for 2436 08 Million of Existing Convertibl 2175 2Cell Therapeutics Inc Announces Issuance of 2423 25 Million in New Convertible Senior Notes in Exchange for 2436 08 Million of Existing Convertibl 2175 3
...ly 9, 2007 - NexMed, Inc.,(NASDAQ: NEXM), a develo...the NexACT(R) drug delivery technology, today anno...t enrollment for Phase,III clinical trials for NM1... fungus). Pursuant to the terms of the licensing,a... a milestone,payment early next year. NexMed enter...
... 2007 - Neurologix, Inc.,(OTCBB:NRGX), a biotechno...ive gene therapies for the brain and central nervo...resent at the Third Annual,C.E. Unterberg Towbin E... at 4:30 pm ET at The Mandarin Oriental Hotel in N...hn Mordock will discuss,Neurologix,s business and ...
Other Medicine Technology:NexMed Announces Completion of Patient Enrollment in Two Pivotal,Phase 3 Studies for Anti-Fungal Product 2
...ratory and a worldwide leader in innovative labora...nsive test menu of highly complex and unique medic... by the University of Utah, ARUP Laboratories' cli...sity teaching hospitals and children's hospitals, ...
...ratory and a worldwide leader in innovative labora...nsive test menu of highly complex and unique medic... by the University of Utah, ARUP Laboratories' cli...sity teaching hospitals and children's hospitals, ...
...ratory and a worldwide leader in innovative labora...nsive test menu of highly complex and unique medic... by the University of Utah, ARUP Laboratories' cli...sity teaching hospitals and children's hospitals, ...
...ratory and a worldwide leader in innovative labora...nsive test menu of highly complex and unique medic... by the University of Utah, ARUP Laboratories' cli...sity teaching hospitals and children's hospitals, ...
Medicine Products: